首页> 外国专利> PROCESS FOR PREPARING FLAVONE-LIGAND PREPARATIONS WITH IMPROVED RELEASE AND RESORBING CAPACITY, IN SUCH A MANNER OBTAINED AGENTS AND THEIR USE FOR PREPARING MEDICAMENTS

PROCESS FOR PREPARING FLAVONE-LIGAND PREPARATIONS WITH IMPROVED RELEASE AND RESORBING CAPACITY, IN SUCH A MANNER OBTAINED AGENTS AND THEIR USE FOR PREPARING MEDICAMENTS

机译:具有获得授权的方式来制备具有增强的释放和重组能力的黄酮配体的工艺及其在制备药物中的用途

摘要

The following are claimed: (A) prodn. of a flavano-lignan (FL) prepn. which has improved release properties compared to pure FL, comprising: (a1) prodn. of an aq.-alcoholic soln. of carriers and wetting agents, suspending an FL in this soln., and heating the resulting mixt. to boiling temp. to give a clear soln.; or (a2) suspending an FL and a wetting agent in alcohol, warming and stirring the suspension until a clear soln. is formed, treating this soln. with an aq. soln. of carriers, and heating and stirring the resulting mixt. until a clear soln. is formed; and (b) concentrating the clear soln. resulting from steps (a1) or (a2) until a coprecipitate is formed, then filtering and drying the coprecipitate. (B) Prepn. of a medicament for prophylactic and/or therapeutic treatment of liver disorders, comprising processing an FL prepn., which is in the form of a co-ppte. of an FL and at least one carrier (such as may be prepd. as described in (A) above) to a dosage form suitable for oral admin. Pref. the carrier is a water soluble sugar deriv. such as a mono- or disaccharide and/or a cellulose deriv. (such as sodium carboxymethyl starch, hydroxyethyl starch or carboxymethylcellulose), or is a linear polymer of 1-vinyl-2-pyrrolidone (such as polyvidone) for disperse systems. The wetting agent is polysorbate (such as polysorbate 80) or a sorbitan ester of a fatty acid.
机译:要求保护以下内容:(A)产品。 flavano-lignan(FL)的制备。与纯FL相比,它具有改善的释放性能,包括:(a1)产品。酒精水溶液载体和润湿剂,将FL悬浮在该溶液中,然后加热所得混合物。到沸腾的温度给出清晰的答案。或(a2)将FL和湿润剂悬浮在酒精中,加热并搅拌该悬浮液直至澄清。形成,处理这种溶液。与水soln。载体,加热并搅拌所得混合物。直到澄清为止。形成了; (b)浓缩透明溶液。由步骤(a1)或(a2)得到的产物直到形成共沉淀物,然后过滤并干燥该共沉淀物。 (B)准备预防性和/或治疗性肝病的药物的制备方法,包括处理呈合肽形式的FL prepn.。将FL和至少一种载体(例如可以如上文(A)所述制备)制成适合于口服给药的剂型。首选载体是水溶性糖衍生物。例如单糖或二糖和/或纤维素衍生物。 (例如羧甲基淀粉钠,羟乙基淀粉或羧甲基纤维素钠),或者是1-乙烯基-2-吡咯烷酮(例如聚维酮)的线性聚合物,用于分散体系。润湿剂是聚山梨酸酯(例如聚山梨酸酯80)或脂肪酸的脱水山梨糖醇酯。

著录项

  • 公开/公告号CZ14296A3

    专利类型

  • 公开/公告日1996-08-14

    原文格式PDF

  • 申请/专利权人 MADAUS AG;

    申请/专利号CZ19960000142

  • 发明设计人 WACHTER WILFRIED DR.;ZAESKE HELGA;

    申请日1996-01-17

  • 分类号A61K35/78;A61K9/14;A61K47/32;

  • 国家 CZ

  • 入库时间 2022-08-22 03:54:43

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号